Opnext Develops Ultra-High Speed SMT Multiplexer IC for 100Gbps Transponder Modules

Opnext, Inc. (NASDAQ:OPXT), a global leader in state-of-the-art laser technology and high speed optical communications, today announced that it has developed the world's first ultra-high speed Surface Mount Technology (SMT) multiplexer Integrated Circuit (IC) for 100Gbps applications.

The SiGe (Silicon Germanium) 0.13(micrometer) process technology chip was designed in-house to be used inside Opnext's leading edge coherent 40Gbps and 100Gbps transponder modules and subsystems. The 128Gbps multiplexer IC transmits the data in 32Gbps lanes suitable for transmission using the DP-QPSK modulation scheme, as documented in the OIF 100G Ultra Long Haul DWDM Framework, for 100GbE and OTU4 transmission in the Wide Area Network (WAN). The multiplexer IC employs Ball Grid Array (BGA) technology to allow standard SMT manufacturing processes. This enables higher density transponder designs with ICs mounted directly onto the Printed Circuit Boards (PCBs).

"One of the major challenges of increasing 40G production was the manufacturability, quality and performance consistency of the hardware," said Roberto Marcoccia, vice president of R&D for Opnext's subsystems business unit. "This SMT IC eliminates the radio frequency (RF) connectors and coaxial cabling, a major source of these volume manufacturing issues."

Opnext continues to employ selective vertical integration on components like this new SMT IC with the goal of delivering the lowest cost and highest performance 100Gbps OIF MSA compliant solution to its OEM partners.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.